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Introduction {#sec1}
============

Inhibition of replication fork progression activates the Mec1^ATR^-mediated checkpoint that phosphorylates downstream effectors such as Rad53^Chk1^ ([@bib6]). Once activated, the replication checkpoint stabilizes stalled replication forks ([@bib49]), stimulates dNTP production ([@bib61], [@bib60]), influences origin firing ([@bib40], [@bib45]), regulates histone protein levels ([@bib26]), and releases topological tensions ([@bib5]). Later in the cell cycle, the spindle assembly checkpoint (SAC) controls the bipolar attachment of chromosomes to microtubules ([@bib18], [@bib41]). Abnormal physical tension between chromosomes and microtubules is sensed at the kinetochore by the Knl1 complex--Mis12 complex--Ndc80 complex (KMN network) ([@bib24]) that recruits the mediator complex Mad1/Mad2 ([Figure 1](#fig1){ref-type="fig"}A). After activation, Mad2 forms a soluble effector complex with the proteins Bub3, Mad3^BubR1^, and Cdc20, which inhibits the anaphase-promoting complex (APC) ([@bib19], [@bib50]). APC inhibition prevents the degradation of mitotic cyclins (Clb2^CyclinB^) and Pds1^Securin^, thus blocking the metaphase/anaphase transition ([@bib47], [@bib57]). Deregulation of SAC protein expression causes chromosome instability and cancer ([@bib46], [@bib52]).Figure 1*MAD2* Deletion Increases the Sensitivity of *rad53* Mutants to Replication Stress(A) Schematic representation of the SAC activation.(A--C) Cells were spotted in 5-fold (A and C) or 2-fold (B) serial dilutions on YPDA/YP-Gal/HU/MMS or camptothecin plates, or on plates irradiated with UV. Relative growth was assayed after 2 days of culture at 28°C. The *rad53-K227A* allele is marked as *rad53*, and the *GAL1-rad53-D339A* allele is marked as *GAL1-rad53.*(D) DNA damage induced by replication stress was monitored by western blot analysis using anti-phosphorylated H2AX antibodies. Cells were synchronized in G1 and released into YPD + 200 mM HU. Pgk1 was used as a loading control.

Despite the persistence of Mad1 and Mad2 proteins throughout the cell cycle, their role outside of mitosis is elusive. During interphase, Mad1 and Mad2 mainly localize to nuclear pores ([@bib10], [@bib13], [@bib34], [@bib38]). In the yeast *Saccharomyces cerevisiae*, Mad1, but not Mad2, favors protein nuclear transport and modulates nuclear import following SAC activation ([@bib9]). Mad2 has been shown to physically interact with proteins involved in transcription, mRNA processing, and translation ([@bib2], [@bib25], [@bib55], [@bib58], [@bib59]), although the involvement of Mad2 in these processes is still elusive.

We found that Mad2 contributes to cell survival in response to replication stress when the Rad53 checkpoint is defective. While Rad53 influences Clb5,6 degradation, Mad2 promotes Clb5,6 protein synthesis through its association with the inhibitor of translation Caf20^4E-BP^. Altogether our observations indicate that Mad2, and not the other SAC proteins, counteracts the association of Caf20 with the translational machinery and stabilizes the complex formation between Caf20 and the initiation factor Cdc33^eIF4E^. Hence, Mad2 acts also during S-phase to promote origin firing and, together with the Rad53-mediated checkpoint, contributes to cell survival in response to replication stress.

Results {#sec2}
=======

Mad2 Contributes to Cell Survival in Response to Replication Stress when Rad53 Is Not Functional {#sec2.1}
------------------------------------------------------------------------------------------------

We investigated whether spindle checkpoint proteins were required for survival to hydroxyurea (HU)-induced replication stress ([@bib32]). The HU sensitivity of *mad1Δ* and *mad2Δ* mutants was comparable to the one of isogenic wild-type (WT) cells ([Figure 1](#fig1){ref-type="fig"}A). However, when combined with the *rad53-K227A* mutation, which retains 10% of Rad53 kinase activity ([@bib62]), *mad2Δ* synergistically enhanced the HU sensitivity of *rad53-K227A*, while Mad2 overexpression ameliorated the *rad53* HU sensitivity ([Figure 1](#fig1){ref-type="fig"}B). *mad1Δ*, *mad3Δ*, and *bub3Δ* did not display any synthetic interactions with the *rad53* mutation, and the triple mutant *rad53-K227A mad1Δ mad2Δ* exhibited the same HU sensitivity of the *rad53-K227A mad2Δ* double mutant ([Figure 1](#fig1){ref-type="fig"}B). Once activated, Mad2 inhibits the APC, which degrades the securin Pds1, thus avoiding premature chromatid separation ([@bib47]) ([Figure 1](#fig1){ref-type="fig"}A). We compared the HU sensitivity of *rad53-K227A pds1Δ* and *rad53-K227A* mutants ([Figure 1](#fig1){ref-type="fig"}B) and found that Pds1 did not contribute to the response to replication stress in a *rad53* background, thus suggesting that the enhanced HU sensitivity of *rad53-K227A mad2Δ* mutants was not caused by premature chromatid segregation. Overexpression of the dominant-negative *rad53-K339A* allele also caused synthetic HU sensitivity when combined with *mad2Δ* ([Figure 1](#fig1){ref-type="fig"}B). We conclude that specifically Mad2, within the SAC apparatus, is required for cell survival to replication stress in a *rad53* background.

Mad2 is the only component of the spindle checkpoint containing a HORMA domain (for *Ho*p1, *R*ev7, and *MA*d2) ([@bib1]); we tested whether the enhanced HU sensitivity caused by *mad2Δ* was a common feature associated with the loss of a protein carrying such a domain. Rev7, a subunit of DNA polymerase zeta, is involved in translesion synthesis, and the HORMA domains of Rev7 and Mad2 can partially substitute for each other *in vitro* ([@bib27]). However, *rev7Δ* did not exhibit any synthetic defect with *rad53* in the presence of HU ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Moreover, *mad2Δ* did not modify the levels of Rad53 phosphorylation in response to replication stress ([Figure S1](#mmc1){ref-type="supplementary-material"}B).

Rad53 mediates cell survival under replication stress conditions but also under DNA damaging conditions. We tested the effect of *MAD2* deletion in cells treated with the alkylating agent methyl methan-sulfonate (MMS); ultraviolet (UV) radiation, which leads to the formation of thymine dimers; or camptothecin (CPT), which forms a covalent complex between topoisomerase I and DNA. In all cases *rad53-K227A* mutants exhibited hypersensitivity compared to WT cells ([Figure 1](#fig1){ref-type="fig"}C); however, the combination of *MAD2* deletion with *rad53-K227A* mutation did not cause synthetic growth defects upon DNA damage ([Figure 1](#fig1){ref-type="fig"}C). These results suggest that *MAD2* deletion specifically affects the HU-induced replication stress response and not the DNA damage response of *rad53-K227A* mutants. Accordingly, the levels of H2AX phosphorylation, a readout of DNA damage, were comparable in WT and *mad2Δ* cells as well as in *rad53-K227A* and *rad53-K227A mad2Δ* mutants ([Figure 1](#fig1){ref-type="fig"}D).

Mad2 Influences Origin Firing in Response to Replication Stress {#sec2.2}
---------------------------------------------------------------

We then investigated whether the absence of Mad2 affected replication dynamics. WT, *mad1Δ*, *mad2Δ*, and *mad1Δ mad2Δ* cells were released from G1 into 200 mM HU for 1, 2, or 3 hr and analyzed by neutral-neutral 2D gels electrophoresis after *in vivo* chromatin psoralen crosslinking ([@bib8]). At 1 hr in HU, all strains accumulated, at the *ARS305* locus, bubble intermediates, a readout of origin firing, and large Y structures, indicative of an asymmetric progression of the sister forks ([Figure S2](#mmc1){ref-type="supplementary-material"}A). The replication intermediates progressively diminished at 2 and 3 hr in HU as a result of fork progression outside the restriction fragment analyzed. The quality and the kinetics of appearance/disappearance of the replication intermediates were comparable in all the strains analyzed. Moreover, the levels of incorporation of bromodeoxyuridine (BrdU), a thymidine analog, analyzed at early origins (*ARS305*, *ARS306*, *ARS607*), and at the centromeric origin *ARS308*, were also comparable in WT and *mad2Δ* strains released from G1 into HU ([Figures S2](#mmc1){ref-type="supplementary-material"}B and S2C). As expected, no BrdU incorporation was detected at inactive origins ([Figure S2](#mmc1){ref-type="supplementary-material"}D). We conclude that the deletion of *MAD2 per se* does not influence origin firing.

We then examined by 2D gels the *ARS305* replication intermediates of *rad53-K227A*, *rad53-K227A mad1Δ*, *rad53-K227A mad2Δ*, and *rad53-K227A mad1Δ mad2Δ* strains released from G1 into HU ([Figure 2](#fig2){ref-type="fig"}A). *rad53-K227A* mutants accumulated the typical intermediates resulting from origin firing and progressive fork collapse ([@bib37]). *rad53-K227A* and *rad53-K227A mad1Δ* mutants exhibited comparable replication profiles. However, the deletion of *MAD2* in a *rad53-K227A* or *rad53-K227A mad1Δ* backgrounds caused a significant reduction (about five times) in the levels of replication intermediates, without altering their kinetics of appearance/disappearance. BrdU immunoprecipitation and quantitative PCR confirmed that the deletion of *MAD2* in *rad53-K227A* mutants reduces origin firing at early origins and extended this observation to late origins (*ARS106*) ([Figures 2](#fig2){ref-type="fig"}B and 2C). We conclude that in the absence of a functional Rad53, *MAD2* deletion leads to a decrease in origin firing efficiency.Figure 2Mad2 Stimulates Origin Firing in *rad53-K227A* Cells(A) 2D gel analysis of replication intermediates in *rad53-K227A*, *rad53-K227A mad1Δ*, *rad53-K227A mad2Δ*, *rad53-K227A mad1Δ mad2Δ* cells at the early origin *ARS305*. Cells were released from G1 into S-phase at 25°C in 200 mM HU. Quantification of replication intermediates was plotted on the histogram. Intensity of the bubble arc was divided by the intensity of the relative monomer spot, normalized against *rad53-K227A* cells.(B and C) BrdU immunoprecipitation and quantitative PCR on early (B) and late (C) origins in *rad53-K227A* and *rad53-K227A mad2Δ* cells. Cells were released from G1 into S-phase at 25°C in the presence of 200mM HU and 200 μg/ml BrdU. BrdU fold increase was calculated as a ratio:IP/input, normalized against BrdU signal of *rad53-K227A* cells after 45 min of release. Scale bars represent the SD of three independent experiments. Asterisks indicate statistically significant differences between cell lines (one-tailed Wilcoxon test with a p value ≤0.05).

Mad2 and the Intra-S Checkpoint promote the Expression of the S-Phase Cyclins Clb5,6 {#sec2.3}
------------------------------------------------------------------------------------

Replication origin firing is a two-step process mediated by origin licensing and origin activation ([@bib3], [@bib14]). During this later step, a subset of the potential origins bound by a pre-replicative complex are converted into active origins through a phosphorylation cascade which involves the DBF4-dependent kinase DBF4/Cdc7 and the cyclin-dependent kinases (CDKs) Clb5/Cdc28 and Clb6/Cdc28. *clb5Δ* cells exhibit a prolonged S-phase, a decrease in late origin firing in the absence of replication stress, and an increased sensitivity to HU ([@bib15], [@bib16], [@bib28]). Moreover, *CLB5* deletion is lethal in combination with a defective intra-S checkpoint, suggesting that Clb5 levels become particularly critical in the absence of a functional intra-S checkpoint ([@bib23], [@bib39]). We investigated whether Clb5 levels were affected by *MAD2* deletion or *RAD53* mutations. WT, *mad2Δ*, *rad53-K227A*, and *rad53-K227A mad2Δ* cells were synchronized in G1 and released into S-phase. Clb5 levels were analyzed throughout the cell cycle by western blotting. As previously described ([@bib29]), Clb5 accumulation started roughly 30 min after release from G1. Its levels peaked after 60 min from release and declined when cells went through mitosis ([Figures 3](#fig3){ref-type="fig"}A and 3B). Clb5 expression profile was similar in *mad2Δ* and WT cells, even though we observed a 40% loss in Clb5 levels at 75 min from the G1 release in *mad2Δ* cells compared to WT. We note that this loss was not due to a faster S-phase since FACS profiles were comparable in WT and *mad2Δ* cells ([Figure 3](#fig3){ref-type="fig"}B). In *rad53* mutants, Clb5 accumulated with similar kinetics to WT cells. The contribution of Mad2 in the maintenance of Clb5 levels was far more evident when comparing *rad53-K227A* and *rad53-K227A mad2Δ* cells. Although the kinetics of Clb5 accumulation were similar between the two strains, Clb5 protein levels were between 30% and 60% less abundant in *rad53-K227A mad2Δ* cells compared to *rad53-K227A* cells (45--90 min after release from G1). Altogether, these results suggest that Mad2 influences the accumulation of Clb5 levels, even in the absence of replication stress.Figure 3Rad53 and Mad2 Regulate Clb5 Expression(A) Expression of Clb5-HA was followed throughout the cell-cycle progression in WT, *mad2Δ*, *rad53-K227A*, and *rad53-K227A mad2Δ* cells by western blot analysis. Pgk1 and Ponceau S were used as loading controls. Cells were released from G1 into S-phase at 25°C in YPD ± 200 mM HU. In the absence of HU, α factor was re-added in the medium after 40 min of release in order to avoid cell re-entry into a new cell cycle. Clb5/Pgk1 signal ratio was plotted for each condition, using WT/*rad53-K227A* cells at 60 min as a reference. The error bars represent the SD of two independent experiments.(B) WT, *mad2Δ*, *rad53-K227A*, and *rad53-K227A mad2Δ* cells were released from G1 into S-phase at 25°C in YPD ± 200 mM HU. The cellular DNA content was determined by FACS analysis at the indicated time points.(C) Total RNAs were extracted from cells synchronized in G1 or released from G1 into S-phase at 25°C in YPD + 200 mM HU. After reverse transcription, the levels of Clb5 mRNA were determined by quantitative PCR. The ratio between the transcription level of *CLB5* and the average expression of two reporter genes (TAF10 and ALG9) was plotted on a histogram. The error bars represent the SD of two independent experiments.(D) Expression of Clb5-HA upon treatment with a proteasome inhibitor (MG132) was followed throughout the cell-cycle progression in WT, *mad2Δ*, *rad53-K227A*, and *rad53-K227A mad2Δ* cells by western blot analysis. Pgk1 and Ponceau S were used as loading controls. Cells were released from G1 into S-phase at 25°C in YPD + 200 mM HU + 100 μM MG132. Clb5/Pgk1 signal ratio was plotted for each condition, using WT cells at 60 min as a reference. The error bars represent the SD of two independent experiments.

We then studied the effect of replication stress on the Clb5 accumulation by releasing cells in complete medium in the presence of HU ([Figure 3](#fig3){ref-type="fig"}A). As previously described ([@bib43]), in WT cells, Clb5 levels peaked 60 min after G1 release both in the presence and in the absence of replication stress. However, Clb5 levels were stabilized for a longer time in the presence of HU (Clb5 expression decline after 90 min of G1-release without HU versus 150 min in the presence of replication stress) ([Figure 3](#fig3){ref-type="fig"}A). Both *MAD2* deletion and *rad53* mutations accelerated Clb5 decline. Indeed, a 60% reduction in Clb5 levels was observed 30 min before in *mad2Δ* and in *rad53-K227A* cells compared to WT. Clb5 reduction was even more pronounced in *rad53-K227A mad2Δ* cells in which Clb5 became hardly detectable. We conclude that both Mad2 and Rad53 contribute to maintain Clb5 levels in the presence of replication stress. Furthermore, their additive effect on Clb5 suggests that Rad53 and Mad2 maintain Clb5 levels though different mechanisms. Similar results were obtained for the other S-phase cyclin, Clb6 ([Figure S3](#mmc1){ref-type="supplementary-material"}A). We note that Mad2 did not affect the general protein expression, since the abundance of the replication factor Orc2, of the cyclin Clb2, or of the housekeeping gene Pgk1, was not reduced by *MAD2* deletion ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

Rad53 Inhibits Clb5 Degradation under Replication Stress {#sec2.4}
--------------------------------------------------------

The decrease in cyclin expression that we have previously observed can result from a defect in transcription, translation, and/or protein degradation. To test the contribution of Rad53 or Mad2 in transcription, WT, *mad2Δ*, *rad53-K227A*, and *rad53-K227A mad2Δ* cells were synchronized in G1 and released into S-phase in the presence of 200 mM HU. mRNA abundance was measured by reverse transcription (RT) and qPCR. As shown in [Figure 3](#fig3){ref-type="fig"}C, Clb5 transcription initiates at the end of the G1 phase, 30 min after α factor release. The levels of Clb5 transcripts were similar in all strains. We conclude that neither *MAD2* deletion nor *rad53* mutation influences Clb5 transcription. Similar results were observed for the other S-phase cyclin, Clb6 ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D).

We then investigated whether Mad2 or Rad53 could have an impact on Clb5 degradation. WT, *rad53-K227A*, and *rad53-K227A mad2Δ* cells were synchronized in G1 and released into S-phase in the presence of 200 mM HU and 100 μM MG132, a proteasome inhibitor, which specifically protects short-lived protein from degradation ([@bib33]). Under MG132 and HU treatment, Clb5 protein levels remained almost constant in WT cells, even after 3 hr of release ([Figure 3](#fig3){ref-type="fig"}D). A similar result was observed in *rad53-K227A* cells. While the levels of Clb5 were reduced by 70% after 150 min of release without MG132, Clb5 levels decreased only by 15% during the same period in the presence of MG132 ([Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}E). We ruled out a cell-cycle issue, since FACS profiles were comparable with or without MG132 (data not shown).

The same strategy was used to study the contribution of Mad2 to Clb5 degradation. Contrary to what we observed in *rad53-K227A* cells, the level of Clb5 gradually decreased under HU treatment in *rad53-K227A mad2Δ* cells, even in the presence of MG132 ([Figure 3](#fig3){ref-type="fig"}D). We conclude that Rad53 protects Clb5 from degradation during HU treatment, while Mad2 acts through a mechanism that is not affected by MG132 treatment.

Mad2 Stimulates Clb5 Synthesis through 4E-BP Inhibition {#sec2.5}
-------------------------------------------------------

High-throughput screenings performed in yeast, human, and plants have previously uncovered some intriguing physical interactions between Mad2 and translation factors ([Table S1](#mmc1){ref-type="supplementary-material"}). These observations, added to our results, suggest that Mad2 could be implicated in Clb5 mRNA translation. To test this possibility, we quantified the translation rate of Clb5 mRNA in *rad53-K227A* and *rad53-K227A mad2Δ* cells ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}). Cells were synchronized in G1 and released into S-phase for 45 min in the presence of HU. Cycloheximide was added to freeze the ribosomes onto the translating mRNAs. Cytoplasmic, monosome, and polysome fractions were separated on a sucrose gradient, and mRNA levels in polysomes (high translation) and monosomes (low translation) were measured by RT-qPCR. We observed that the deletion of *MAD2* shifted Clb5 mRNA from heavy polysomes to smaller polysomes and monosomes, confirming that Mad2 may impact the translation process of Clb5 mRNA ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}). We then investigated whether Mad2 co-sediments with polysomes by performing a western blot analysis on sucrose gradient fractions ([Figure 4](#fig4){ref-type="fig"}B). We observed that Mad2 co-fractionated with heavy polysomes in an EDTA- and RNase I-dependent manner (addition of EDTA leads to the separation of the 40S and 60S ribosomal subunits while RNase I is an endoribonuclease that preferentially degrades single strand RNA). This result supports the hypothesis that Mad2 interacts with the translational machinery. Interestingly, in *S. cerevisiae*, two independent screenings identified the translation factor Caf20 as a physical partner of Mad2 ([@bib11], [@bib25]). Caf20 has been identified as a repressor of the cap-dependent translation and as a homolog of the eIF4E binding proteins (4E-BP). Consequently, we investigated whether Mad2 could control Clb5 expression through a Caf20-dependent mechanism. *rad53-K227A*, *rad53-K227A caf20Δ*, *rad53-K227A mad2Δ*, and *rad53-K227A mad2Δ caf20Δ* cells were released from G1 into 200 mM HU. Clb5 expression was analyzed by western blot analysis ([Figure 4](#fig4){ref-type="fig"}C). The level of Clb5 protein remained similar in *rad53-K227A* and *rad53-K227A caf20Δ* cells, whereas Clb5 level increased in *rad53-K227A mad2Δ caf20Δ* in comparison of *rad53-K227A mad2Δ* cells. In addition, we found that the deletion of *CAF20* suppressed the effect of *MAD2* deletion on Clb5 mRNA translation ([Figure 4](#fig4){ref-type="fig"}A). Altogether, these results show that Mad2 impacts Clb5 mRNA translation in a Caf20-dependent manner.Figure 4Mad2 Controls Clb5 mRNA Translation via a Caf20-Dependent Mechanism(A) Translational rate of Clb5 mRNA in *rad53-K227A*, *rad53-K227A mad2Δ*, and *rad53-K227A mad2Δ caf20Δ* cells. Cells were released from G1 into 200 mM HU for 45 min at 25°C. Polysome/monosome ratio (Poly/Mono) at the global level or on Clb5 mRNA was plotted for each strain using *rad53-K227A* as a reference. Error bars represent the SD of two independent experiments.(B) Mad2, Pgk1, and Rps6 protein distribution across the sucrose gradient was analyzed by western blotting in the absence or in the presence of EDTA/RNase I.(C) Expression of Clb5-HA was followed throughout the cell-cycle progression in *rad53-K227A*, *rad53-K227A caf20Δ*, *rad53-K227A mad2Δ*, and *rad53-K227A mad2Δ caf20Δ* cells by western blot analysis. Pgk1 and Ponceau S were used as loading controls. Cells were released from G1 into 200 mM HU at 25°C. Clb5/Pgk1 signal ratio was plotted for each condition, using *rad53-K227A* and *rad53-K227A mad2Δ* cells at 60 min as a reference. Error bars represent the SD of two independent experiments for rad53-K227A versus rad53-K227A caf20Δ cells and of three independent experiments for *rad53-K227A mad2Δ* versus *rad53-K227A mad2Δ caf20Δ* cells. Cell-cycle progression of *rad53-K227A mad2Δ* and *rad53-K227A mad2Δ caf20 Δ* cells was determined by FACS analysis.(D) BrdU ImmunoPrecipitation and quantitative PCR on four early (*ARS305*, *ARS306*, *ARS607*, and *ARS308*) and one late (*ARS106*) origins in *rad53-K227A mad2Δ* and *rad53-K227A mad2Δ caf20Δ* cells. Cells were released from G1 into S-phase for 45 min at 25°C in the presence of 200 mM HU and 200 μg/ml BrdU. BrdU fold increase was calculated as a ratio: IP/input, normalized against BrdU signal of *rad53-K227A mad2Δ*. Error bars represent the SD of two independent experiments.(E) Cells were spotted in 2-fold serial dilutions on YPDA/HU plates. Relative growth was assayed after 2 days of culture at 28°C. The *rad53-K227A* allele is marked as *rad53.*

Since *CAF20* deletion restores the Clb5 expression in *rad53-K227A mad2Δ* cells, we investigated the effect of *CAF20* deletion on replication origin firing and HU resistance. As expected, we observed a global increase in origin firing in *rad53-K227A mad2Δ caf20Δ* cells compared to *rad53-K227A mad2Δ* cells ([Figure 4](#fig4){ref-type="fig"}D). In agreement with this result, *CAF20* deletion suppressed the HU sensitivity observed in *rad53-K227A mad2Δ* cells ([Figure 4](#fig4){ref-type="fig"}E). Hence, Mad2 inhibits the 4E-BP Caf20, which in turn counteracts Clb5 synthesis and efficient origin firing.

Mad2 Modifies the Interaction of Caf20 with the Translational Machinery {#sec2.6}
-----------------------------------------------------------------------

Mad2 could inhibit Caf20 by at least two different mechanisms: preventing its loading onto mRNA or counteracting its activity. To test the first possibility, *rad53-K227A* and *rad53-K227A mad2Δ* cells were released from G1 into S-phase for 45 min in the presence of HU. Protein complexes were fixed onto mRNA with formaldehyde. mRNAs bound to Caf20-HA were co-immunoprecipitated with an anti-HA antibody, reverse transcribed, and quantified using quantitative PCR. As it was previously described ([@bib11], [@bib12]), we found that Caf20 was strongly bound to its own mRNA ([Figure S5](#mmc1){ref-type="supplementary-material"}). In addition, we observed that Clb5 mRNA was also bound by Caf20. We confirmed that this association was specific, since the attachment of Caf20 onto Clb5 mRNA was higher compared to the binding of Caf20 onto a negative control (Alg9 mRNA). However, we found that the deletion of *MAD2* did not significantly modify the recruitment of Caf20 onto Clb5 mRNA. This result implies that Mad2 inhibits Caf20 by a mechanism that is independent of the recruitment of Caf20 onto mRNAs.

We then investigated whether Mad2 could counteract the activity of Caf20 by altering its interaction with the translational machinery. *rad53-K227A* and *rad53-K227A mad2Δ* cells were synchronized in G1 and released into S phase for 45 min in the presence of HU. We did not observe significant differences in Caf20 protein levels by western blotting in the two strains (data not shown). Caf20-HA and its interactors were co-immunoprecipitated. Protein partners were identified and quantified by mass spectrometry. As it was previously described ([@bib12]), we found that Caf20 interacts with a large number of translation factors implicated in both initiation and elongation ([Figures 5](#fig5){ref-type="fig"}A and 5B; [Table S2](#mmc2){ref-type="supplementary-material"}). In addition, we observed that, in the absence of Mad2, Caf20 globally increases its association with the whole translational machinery (translational initiation factors and ribosomal proteins). Conversely, only the translational initiation factor eIF4E (Cdc33) reduced its affinity for Caf20 in the absence of Mad2 ([Figure 5](#fig5){ref-type="fig"}B). We conclude that Mad2 hinders the stable association between Caf20 and the translation machinery, while it specifically stabilizes the binding of Caf20 with eIF4E.Figure 5Mad2 Affects the Recruitment of the Translational Machinery(A and B) *rad53-K227A* CAF20-HA, *rad53-K227A mad2Δ* CAF20-HA cells were released from G1 into S-phase at 25°C in 200 mM HU for 45 min. Proteins interacting with Caf20 (A, ribosomal proteins; B, initiator factors) were co-immunoprecipitated using an anti HA antibody and identified by mass spectrometry. Statistically significant differences between *rad53-K227A* and *rad53-K227A mad2Δ* cells were plotted on a logarithmic scale so that higher interaction in *rad53-K227A mad2Δ* cells is shown as a positive number. (Red) Interactors enriched in *rad53-K227A mad2Δ* cells; (green) interactor enriched in *rad53-K227A* cells.(C) Model for the translational regulation of the S-phase cyclin mRNAs by Mad2. Mad2 regulates the affinity of Caf20 for the translational machinery. Mad2 decreases the association Caf20/ribosomes while it stabilizes the association Caf20/Cdc33.

Discussion {#sec3}
==========

Many oncogenes and tumor suppressors target cyclins and CDKs. For example, cMyc promotes Cyclin D/E/A transcription ([@bib7]), while p53 favors the transcription of p21, a CDK inhibitor ([@bib21]). In this study, we uncovered a Mad2-mediated regulatory circuit promoting S-phase cyclin expression. In particular, the levels of Clb5 and Clb6 are compromised when Mad2 is ablated in unperturbed conditions and in response to replication stress. Mad2 is a well-known effector of the spindle checkpoint, but its S-phase function is independent of the other SAC components like Mad1, Mad3, and Bub3. Moreover, since Mad1 also favors the proper localization of Mad2 at the kinetochore during mitosis and at the nuclear pore during interphase ([@bib10], [@bib13], [@bib34], [@bib38]), our results imply that the S-phase function of Mad2 influencing Clb5 expression does not depend on its localization at the kinetochore or at the nuclear pores. We ruled out a contribution of Mad2 in promoting Clb5 transcription or in regulating its degradation. Our results rather indicate that Mad2 promotes an optimal Clb5 protein synthesis.

Previous high-throughput studies have already identified some interactions between Mad2 and translational factors ([Table S1](#mmc1){ref-type="supplementary-material"}), and to our knowledge, Mad2 is the only component of the spindle checkpoint which presents such interactions. Here we found that Mad2 co-sediments with translating ribosomes ([Figure 4](#fig4){ref-type="fig"}B) and that Mad2 directly promotes the translation of Clb5 mRNA via a Caf20-dependent mechanism ([Figure 4](#fig4){ref-type="fig"}A). We observed that Caf20 binds Clb5 mRNA, regardless of the presence or the absence of Mad2 ([Figure S5](#mmc1){ref-type="supplementary-material"}). Recent studies demonstrated that Caf20 is recruited onto mRNAs via its interaction with the eIF4E factor, or via its fixation on the 3′UTR motif present on mRNAs. Interestingly, Clb5 and Clb6 mRNA share the properties of the 4E-independent recruitment. Indeed, both of them present a Caf20 consensus sequence in their 3′UTR ("AUAUAUAUGUAUAUA" localized 100 nt after the stop codon in Clb5 mRNA). We found that Mad2 changes the affinity of Caf20 for its protein partners ([Figures 5](#fig5){ref-type="fig"}A and 5B). In the absence of Mad2, the association of Caf20 with the translational machinery increases, probably negatively regulating the translation rate. In parallel, in the absence of Mad2, Caf20 has less affinity for eIF4E ([Figure 5](#fig5){ref-type="fig"}C). We have no direct evidence to argue for a competition between eIF4E and the translation machinery, but it is interesting to note that the same tendency has already been observed for a Caf20 mutant that has a defective eIF4E binding ([@bib11]).

We also found that, in response to replication stress, Rad53 controls Clb5 protein degradation ([Figure 3](#fig3){ref-type="fig"}). Interestingly, Clb6 protein degradation upon replication stress is also dependent on Rad53 ([@bib43]). Although Clb5 stabilization occurs in response to both replication stress and intra-S DNA damage (MMS, treatment), the mechanisms seem different ([@bib22]). In particular, the proteolysis inhibition observed in the presence of DNA damage is independent of the checkpoint proteins Mec1 and Rad53 ([@bib22]). This observation could explain why *rad53-K227A mad2Δ* cells are specifically sensitive to HU and not to other DNA damaging agents. Contrary to Rnr1, whose transcription level is maintained during the duration of S-phase upon replication stress through a Rad53 dependent mechanism ([Figure S3](#mmc1){ref-type="supplementary-material"}D; [@bib54]), we note that we did not find evidence for a contribution of Rad53 in prolonging Clb5 or Clb6 transcription upon replication stress ([Figures 3](#fig3){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}D).

Importantly, the Rad53-Mad2 synergistic and specific effect in response to replication stress seems to be at least partially conserved between different yeast species. Indeed, previous observations in *S. pombe* also underlined that (1) *MAD2* and *CDS1* (*RAD53* homolog) exhibit a negative genetic interaction in the presence of replication stress; (2) this interaction is specific for *MAD2* over the other components of the spindle checkpoint (*MAD1*, *MAD3*, and *BUB1*); and (3) this interaction is specific to the cellular response to replication stress and not to DNA damage ([@bib51]). However, while in *S. pombe* the APC is hyperactivated in the absence of Mad2, we did not find any increase in APC activity in *S. cerevisiae* (no modification of Clb2 degradation). On the contrary, we proposed that Mad2 interferes with the translation process. It is particularly interesting to note that physical interactions between the spindle checkpoint protein Mad2 and the translational machinery have already been identified in different organisms including plants and humans ([Table S1](#mmc1){ref-type="supplementary-material"}).

The Mad2 function described in our paper may have relevant implications for cancer cells. Expression of SAC proteins is often deregulated in tumor cells. However, Mad2 deregulation is particularly prominent over the other spindle checkpoints proteins. Oncomine database analysis revealed that only 2% of cancer cells show an upregulated expression of Mad1, whereas 18% of cancer cells exhibit Mad2 upregulation. This specific increase is particularly relevant in colorectal cancer, in which one-third of the tumor tissue analyzed exhibits an overexpression of Mad2. An additional role of Mad2 out of the spindle checkpoint could explain the particular prominence of Mad2 deregulation. It is also worth noting that many cancer cells exhibit a delocalization of Mad2 protein from the nucleus to the cytoplasm ([@bib20], [@bib36]), a cellular compartment in which Mad2 is not functional as a spindle checkpoint player ([@bib30]) but could be fully functional as a regulator of the translation process. Given that differences exist between yeast and mammals at the level of 4E-BP regulation, more work will be required to address whether Mad2 affects protein translation also in mammalian cells.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Mouse monoclonal anti-phosphorylated Rad53In house ([@bib17])Clone F9Mouse monoclonal anti-phosphorylated histone H2X (ser139)MerckClone JBW301 Cat \#05-636Mouse monoclonal anti-Pgk1ThermoFisher ScientificClone 22C5D8 Cat \#459250Rabbit polyclonal anti-Clb2Santa-Cruz BiotechnologyCat \#sc9071Mouse monoclonal anti c-MYC (clone 9E10)Santa Cruz BiotechnologyCat \#sc-40Mouse monoclonal anti HABiolegendClone 16B12 Cat \#901503Mouse monoclonal anti BrdUMBLClone 2B1 Cat \#MI-11-3Rabbit polyclonal anti Mad2In house ([@bib56])Clone IEO447SI353FRabbit polyclonal anti Rps6ABCamCat **\#**ab40820Goat anti-Mouse IgG (H + L)-HRP ConjugateBio-RadCat **\#**1706516Goat anti-Rabbit IgG (H + L)-HRP ConjugateBio-RadCat **\#**1706515**Chemicals, Peptides, and Recombinant Proteins**HydroxyureaSigma-AldrichCat \#H8627Methyl methanesulfonate (MMS)Sigma-AldrichCat \#129925MG132Sigma-AldrichCat \#M8699CicloheximideSigma-AldrichCat **\#**C7698CamptothecinSigma-AldrichCat \#208925Anti-HA.11 Epitope Tag Affinity MatrixBiolegendCat \#900801Dynabeads Protein AThermoFisher ScientificCat \#10001D**Critical Commercial Assays**Genomic DNA buffer genomic setQIAGENCat **\#**19060Genomic tip 100/GQIAGENCat **\#**10243Rneasy Mini KitQIAGENCat **\#**74104PCR purification kitQIAGENCat **\#**28106QuantiFast SYBR green PCR kitQIAGENCat **\#**204054**Deposited Data**Proteomic raw dataPeptide Atlas repository<http://www.peptideatlas.org/PASS/PASS01156>Raw DataMendeley Data<http://dx.doi.org/10.17632/wwcrg942cf.1>**Experimental Models: Organisms/Strains**All *Saccharomyces cerevisiae* yeast strains used in this study were W303 derivatives; they are listed in [Table S3](#mmc1){ref-type="supplementary-material"}This studyN/A**Oligonucleotides**See [Table S4](#mmc1){ref-type="supplementary-material"} for a list of oligonucleotides used in this studySigma-AldrichN/A**Recombinant DNA**pCH12 (*GAL1- rad53-D339A)*[@bib44]N/A**Software and Algorithms**Image Quant softwareGE Healthcare<https://www.gelifesciences.com/shop/protein-analysis/molecular-imaging-for-proteins/imaging-software/imagequant-tl-8-1-p-00110?current=29000737>Image Lab softwareBio-Rad<http://www.bio-rad.com/en-ch/product/image-lab-software>PerseusMax Planck Institute<http://www.perseus-framework.org>CellQuestBD Biosciences<http://www.bd.com/en-uk/products/molecular-diagnostics/cytometric-analysis-products>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Marco Foiani (<marco.foiani@ifom.eu>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

The list of yeast strains used in this study is available in the [Key Resources Table](#sec4.1){ref-type="sec"} ([Table S3](#mmc1){ref-type="supplementary-material"}). Yeast strains are derived from W303 background (*S. cerevisiae).* All strains, except *cdc33* mutants, are corrected with the wild-type RAD5 locus. Gene deletions and carboxy-terminal tags were carried out using a standard PCR-based strategy to amplify resistance cassettes with appropriate flanking sequences, and replacing the target gene by homologous recombination. All strains, except *rad53-D339A* mutants, carry a repetition of the thymidine kinase (TK) at the URA3 locus in order to allow BrdU incorporation ([@bib35]). *GAL1- rad53-D339A* plasmid was previously described in ([@bib44]). Strains were grown at 25°C in yeast extract/peptone with 2% glucose (YPD) or in synthetic complete medium lacking uracil. Exponentially growing cells (10^7^cells/ml) were arrested in G1 using α factor (5 μg/ml). Before release, cells were washed in YP. HU was added at 0.2M, BrdU at 0.2mg/ml and MG132 at 100 μM.

Methods Details {#sec4.4}
---------------

### Drug sensitivity assay {#sec4.4.1}

Cells were grown in liquid culture overnight, counted, adjusted to 8X10^7^cells/ml and diluted before being spotted on YPD plates supplemented with adenine (YPDA) containing indicated concentrations of HU, MMS or Camptothecin. Plates were incubated for 2 days at 28°C. Note that serial dilutions of 1:2 were made for *rad53* mutant cells plated on HU while serial dilutions of 1:5 were made in all other cases. *rad53-D339A* mutants were spotted on synthetic growth medium plates deprived of uracil to maintain the plasmid selection.

### Protein extraction and Western Blot analysis {#sec4.4.2}

Protein extracts for western blotting were prepared following cell fixation using trichloroacetic acid and analyzed by SDS-polyacrylamide gel electrophoresis (gel 4/15% Criterion TGX, Biorad). Briefly, cells were quickly spun down and the pellet was resuspended in 20% TCA and lysed by bead beating. Lysate and precipitate/debris was mixed with 200 μL 5% TCA and pelleted. The pellet was resuspended in 100 μL Laemmli buffer 1X (β-mercaptoethanol as reducing agent*)* and 50 μL Tris base 1M, boiled for 5 min. After centrifugation, the supernatant was transferred in new tubes.

Antibodies used for detection are listed in the [Key Resources Table](#sec4.1){ref-type="sec"}. Detection was done through electrogenerated chemiluminescence (ECL, GE- Healthcare). Quantification was done using Image Lab software (Bio-Rad).

### 2D Gel Electrophoresis of replication intermediates {#sec4.4.3}

200ml of exponentially growing cell culture was harvested in the presence of 1% sodium azide and cooled on ice for 15 minutes. Cells were then subjected to *in vivo* psoralen cross-linking. Briefly, cells were washed, resuspended in 5ml of cold water in small Petri dishes and kept on ice. 300 μL of 4,5′,8-tri-methyl-psoralen solution (0.2 mg/ml in EtOH 100%) was added prior to extensive resuspension by pipetting, followed by 5 min of incubation in the dark and then 10 min of UV irradiation at 365 nm (Stratagene UV Stratalinker). The procedure was repeated 3 times. Cells were centrifuged and resuspended in 5ml of nuclear isolation buffer (17% glycerol, 50mM MOPS, 2mM MgCl2, 150mM Kacetate, 0.5mM spermidine, 0.15mM spermine, pH 7.2) and mechanically lysed using an equal volume of glass beads (Sigma, G8772). After centrifugation (8000 rpm, 10 min, 4°C), the pellet was resuspended in 5ml of G2 buffer (Genomic extraction kit, QIAGEN). Genomic DNA extraction was performed according to manufacturer recommendations. 4 μg of genomic DNA was digested overnight with 200 units of *NcoI* enzyme and then precipitated with 1/8 volume of Kacetate and one volume of isopropanol. Signals were detected following 2D gel electrophoresis ([@bib8]) and standard Southern blot procedures using a probe against *ARS305* (Chr III 39002-40063). Quantification of bubble arc signal was performed using the Image Quant software (GE Healthcare).

### BrdU immuno-precipitation {#sec4.4.4}

150 mL of exponentially cell culture was synchronized in G1, released into S-phase in the presence of 200mM HU and 200 μg/ml BrdU. At different time points, cells were harvested in the presence of 1% sodium azide and cooled on ice for 15 minutes. Cells were then washed in 20ml of TE and the genomic DNA was extracted using the Genomic extraction kit (QIAGEN) according to manufacturer recommendations. BrdU immuno-precipitations were performed as previously described ([@bib4], [@bib31]). DNA was then resuspended overnight in 250 μL of TE and then shared using the Bandelin UW2070 sonicator (6 pulses, 20% power, 20 s/pulse). Immediately before immunoprecipitation, the genomic DNA was denatured at 100°C for 10 minutes, cooled immediately on ice and supplemented with 100 μL of ice cold PBS 2x and 200 μL of ice cold-PBS 1X-2% BSA-0,2% Tween20. BrdU immunoprecipitation was carried out overnight using 14 μg of genomic DNA, 20 μL of Protein A-magnetic Dynabeads (Thermofisher) and 4 μg of anti-BrdU antibody (clone 2B1, MBL, MI-11-3). 700ng of DNA was kept as an input. After immuno-precipitation, beads were washed 2 times with ice cold lysis buffer (50mM HEPES-KOH pH7.5, 140mM NaCl, 1mM EDTA, 1% Triton x100, 0.1% Na-deoxycholate), 2 times with ice-cold lysis buffer + 500mM NaCl, 2 times with ice-cold washing buffer (10mM Tris-HCl pH8.0, 250mM LiCl, 0.5% NP40, 0.5% Na-deoxycholate, 1mM EDTA) and once with TE. Beads were then resuspended in 50 μL of elution buffer (50 mM Tris-HCl pH8, 10 mM EDTA, 1% SDS), incubated at 65°C for 10 minutes with shaking. After centrifugation and magnetic attachment, the supernatant was transferred into a new tube. 49 μL of TE and 1 μL of proteinase K 50 mg/ml was added to both IP and input tubes. Tubes were incubated at least 2 hours at 37°C. DNA was then purified using the PCR purification Kit (QIAGEN), eluted in 50 μL of the elution buffer of the kit and precipitated at −20°C overnight in the presence of 40mM Na- acetate, 1 μL of glycogen and 132.5 μL of 100% ethanol. After centrifugation, the pellet was washed in 70% ethanol, dried and resuspended in 50 μL of bi-distillated water. Input DNA was diluted 50 times and IP DNA 10 times before quantitative PCR.

### Quantitative PCR {#sec4.4.5}

Primers used for quantitative PCR are listed in [Table S4](#mmc1){ref-type="supplementary-material"}. Quantitative PCR was prepared using QuantiFast SYBR green PCR kit (QIAGEN) and run on the Lightcycler 480II (Roche) according to the manufacturer's recommendations. Absolute DNA quantification was deduced from standard curve (100; 10; 1 and 0.1ng of input DNA).

### RNA extraction and reverse transcription {#sec4.4.6}

Total mRNAs were extracted from 2.5x10^7^ cells using the RNeasy mini kit (QIAGEN). Reverse transcription was performed using the SuperScript VILO cDNA synthesis kit (Invitrogen) with 2 μg of total RNA as starting material. 1/160 of the cDNA reaction was used for quantitative PCR. Two reporter genes (TAF10, ALG9) were chosen for their robustness ([@bib53]) and their distance from replication origins (minimum 12 kb). Normalization was done by dividing the expression of the gene of interest by the average of the two reporter genes.

### Fluorescence-activated cell sorter (FACS) analysis {#sec4.4.7}

1x10^7^cells were collected by centrifugation, and resuspended overnight in 70% ethanol/ 250mM Tris-HCl (pH 7.5) solution. Cells were then centrifuged and resuspended in 0.5M Tris-HCl (pH 7.5), resuspended in the same buffer containing 2 mg/ml of RNaseA and incubated at 37°C for at least 2h. Cells were then resuspended in 500 μL of 200mM Tris-HCl (pH 7.5), 200mM NaCl, 80mM MgCl~2~ supplemented by 50 μg/ml of propidium-iodide (Sigma). Samples were then diluted 10-fold in 50mM Tris-HCl (pH 7.5) and analyzed using a Becton Dickinson FACScan and the Cellquest software.

### Non-denaturing protein Co-immunoprecipitation {#sec4.4.8}

2^∗^10^9^ cells were used for each immunoprecipitation. Cell pellet was washed two times in 50ml of TE, and resuspended in 1.6ml of JS buffer (35mM HEPES pH7.5, 105mM NaCl, 0.7% glycerol; 0.7% Triton, 1 mM MgCl~2~, 3.5mM EDTA, 1 tablet of Phostop-phosphatase inhibitor Roche, 1 tablet of Ultra-protease inhibitor-Roche). The same quantity of zirconium beads was added to the cell suspension and cells were mechanically disrupted at 4°C thanks to the use of a bead-beater. Cell lysate was collected using a gel tip (thin diameter to avoid beads) and proteins were quantified using the Bradford Protein Assay (Biorad). Proteins associated to Caf20-HA were immunoprecipitated overnight using 80 μL of Sepharose beads covalently coupled to an anti-HA antibody (Biolegend). After immunoprecipitation, beads were washed once with JS buffer, two times with JS buffer supplemented with 350 mM NaCl, and two times with JS buffer. At the last step, beads were resuspended in 40 μL of Laemmli buffer, boiled during 6 minutes at 98°C, and centrifuged. The supernatant was analyzed by SDS-polyacrylamide gel electrophoresis. Note that pre-lubricated tubes were used at all stages to avoid protein adherence.

### Mass-spectrometry (MS) {#sec4.4.9}

#### Protein digestion and peptide preparation {#sec4.4.9.1}

Gel lanes were processed according to STAGE-diging protocol ([@bib48]). The entire protocol occurs in a p1000 tip (Sarstedt 70.762.100) filled at the orifice with a double C18 Empore Disk (3M, Minneapolis, MN) plug, named STAGE-diging tip. Briefly, after Coomassie staining, the entire lane was carefully cut into ∼1 mm^3^ cubes and transferred into the STAGE-diging tip. These gel cubes were dehydrated with 100% acetonitrile (CAN, Carlo Erba) and rehydrated in 100 mM NH~4~HCO~3~ (Sigma) twice before being dehydrated by the addition of ACN. To ensure that the gel pieces do not create a sticky surface on the C18, all the solutions were added with a gel-loader tip. The removal of solutions was accomplished by centrifugation at 1800 rpm using the commercial tip box as holder. Reduction of protein disulfide bonds was carried out with 10 mM dithiothreitol (DTT) in 100 mM NH~4~HCO~3~ and subsequent alkylation was performed with 55 mM iodoacetamide (IAA) (Sigma), in complete darkness, in 100 mM NH~4~HCO~3,~ at room temperature for 30 min. Both DTT and IAA were removed by centrifugation or by syringe as previously described. The gel pieces were rehydrated and dehydrated with 100 mM NH~4~HCO~3~ and ACN respectively prior to digestion. Gel pieces were rehydrated with 40 μL of Trypsin (12.5 ng/μL in 100 mM NH~4~HCO~3~), after few minutes 60 μL of NH~4~HCO~3~ were added and samples were incubated at 37°C o/n in a commercial tip box filled by water on the bottom to ensure that buffer will not evaporate. The digestion solution was then forced through the double plug with a syringe and the flow through was collected. Samples were acidified with 100 μL of 0.1% formic acid (FA, Fluka), forced with the syringe and collected as flow-through. In this way the desalting of peptides occurs. Peptides were eluted twice by adding 100 μL of a solution composed of 80% ACN, 0.1% FA, an extra step of extraction with 100% ACN was performed and then all the eluates were dried in a Speed-Vac and resuspended in 15 μL of solvent A (2% ACN, 0.1% formic acid). 3 μL were injected for each technical replicate on the Q-Exactive --HF mass spectrometer.

#### MS analysis and proteins quantification {#sec4.4.9.2}

Mass spectrometry analysis was carried out by LC--MS--MS on a quadrupole Orbitrap Q Exactive HF mass spectrometer (Thermo Scientific). Peptide separation was achieved on a linear gradient from 95% Solvent A to 50% Solvent B (80% acetonitrile, 0.1% formic acid) over 20 min and from 50% to 100% Solvent B in 2 min at a constant flow rate of 0.25 μl min^−1^ on a UHPLC Easy-nLC 1000 (Thermo Scientific), where the LC system was connected to a 25 cm fused-silica emitter of 75 μm inner diameter (New Objective), packed in house with ReproSil-Pur C18-AQ 1.9 μm beads (Maisch) using a high-pressure bomb loader (Proxeon). MS data were acquired using a data-dependent top15 method for HCD fragmentation.

Survey full scan MS spectra (300--1750 Th) were acquired in the Orbitrap with 60,000 resolution, AGC target 1e6, IT 120 ms. For HCD spectra the resolution was set to 15,000, AGC target 1e5, IT 120 ms; normalized collision energy 28 and isolation width 3.0 *m*/*z*.

2 technical replicas of each sample were carried out. Raw data were processed with MaxQuant version 1.5.2.8. Peptides were identified from the MS--MS spectra searched against the uniprotKB\_*S.Cerevisiae* database (3845 entries canonical + isoforms) using the Andromeda search engine, in which trypsin specificity was used with up to two missed cleavages allowed.

Cysteine carbamidomethylation was used as a fixed modification, methionine oxidation and protein amino-terminal acetylation as variable modifications. The mass deviation for MS and MS--MS peaks was set at 4.5 and 20 ppm respectively. The peptide and protein false discovery rates (FDRs) were set to 0.01; the minimal length required for a peptide was six amino acids; a minimum of two peptides and at least one unique peptide were required for high-confidence protein identification. The lists of identified proteins were filtered to eliminate reverse hits and known contaminants.

Label-free analysis was carried out, including a 'match between runs' option (time window of 5 min). A minimum ratio count of 2 was considered and the 'LFQ intensities', which are the intensity values normalized across the entire dataset, were used. 2 Biological and 2 technical replicates for every condition were submitted in a single MaxQuant run.

Statistical t test analyses were done using the Perseus program (Version 1.5.1.6) in the MaxQuant environment. For all the statistical analysis an FDR 0.05 was applied using a permutation test (500 randomizations) and S0 = 1.

Gene ontology annotation for biological process and molecular function was manually added by [uniprot.org](http://uniprot.org){#intref0040}. Proteins belonging to translational process and ribosomal assembly (list of GO selected is reported in the [Table S2](#mmc2){ref-type="supplementary-material"}, sheet Go_table) were filtered and only proteins with a valid ratio in both biological replicates were selected.

Ratios of the 2 biological replicates were averaged and plotted in logarithmic scale. Standard deviations were calculated and represented on the plot.

### RNA co-immunoprecipitation {#sec4.4.10}

2^∗^10^9^ cells were used for each immunoprecipitation. Proteins were fixed onto RNA with 1% formadehyde at 4°C. *In vivo* crosslinking was stopped by addition of 0.1M glycine. Cells were washed four times with 20mL of water. After centrifugation, the cell pellet was resuspended in 0.8ml of Buffer A (20mM Tris-HCl pH8, 140mM NaCl, 1 mM MgCl~2~, 0.5 mM DTT, 1 tablet of Phostop-phosphatase inhibitor Roche, 1 tablet of Ultra-protease inhibitor-Roche, and 80U/ml RNasin-Promega).The same quantity of zirconium oxide beads was added to the cell suspension and cells were mechanically lysed thanks to the use of a bead-beater. The lysate was recovered with a gel tip (to avoid beads) and centrifuged. Proteins of the supernatant were quantified using the Bradford Protein Assay (Biorad). 20mg of protein extract and 120 μL of Sepharose beads coupled with anti-HA antibody were used for overnight immunoprecipitation. 1mg of protein extract was kept as an input. After immunoprecipitation, beads were washed 3 times shortly with Buffer A, two times 15 minutes with Buffer A, and three times with the Rnase III buffer (10mM Tris-HCl pH8, 10mM MgCl2, 60mM NaCl, 1mM DTT, 10U/ml RNasin-Promega). At the final wash, beads were resupended in 100 μL of Rnase III buffer supplemented by 40U RNasin, 1U DNase I, 2U RNase III, and incubate 10 minutes at 37°C. RNase III was deactivated by addition of 900 μL of Buffer E (20mM Tris-HCl pH8, 140mM NaCl, 0.5% NP40, 1mM EDTA, 0.5 mM DTT, 40U/ml RNasin-Promega). Beads were further washed three more times with buffer E. At the last wash, beads were resuspended in 270 μL of proteinase K buffer (10mM Tris-HCl pH8, 200mM NaCl, 1mM EDTA, 0.1% SDS, 10U/ml RNasin-Promega). Proteinase K buffer up to 270 μL was also added to the input samples. 50 μg of proteinase was added to IP and input and the samples were incubated for two hours at 40°C. After centrifugation, the supernatant was transferred into a new tube and incubated overnight at 65°C to reverse the crosslink. 750 μL of Trizol and 200 μL of Chloroform was added to each sample and the aqueous phase was collected. RNA was precipitated overnight at −20°C by addition of 500 μL of propanol and 1 μL of glycogen. After centrifugation, RNA pellet was washed in 70% ethanol and resuspended in 30 μL of bi-distillated water for IP samples and 20 μL of water for Input samples. Total mRNAs were then reverse-transcribed and amplified by quantitative PCR.

### Polysome profiling {#sec4.4.11}

*Cell lysis.* 2^∗^10^9^ cells were used for each polysome profiling experiment. 100 μg/ml of cycloheximide was added for 5 minutes to each sample to "freeze" ribosomes onto RNAs. Cells were centrifuged, washed two times with 7 mL of pre-lysis buffer (20mM Tris-HCl pH8, 50mM KCl, 10mM MgCl~2~, 1mM DTT, 100μg/mL cycloheximide, 200 μg/mL heparin) and then resuspended in a volume of lysis buffer (20mM Tris-HCl pH8, 50mM KCl, 10mM MgCl~2~, 1mM DTT, 100μg/mL cycloheximide, 200μg/mL heparin, Ultra-protease inhibitor 1X-Roche, and 40U/ml RNasin-Promega) equivalent to the cell pellet size. An equal volume of zirconium beads was added to the cell suspension and cells were mechanically lysed thanks to use of a bead-beater. Lysate was recovered and cleared by centrifugation.

*Polysomal profiles.* 15 and 50% sucrose buffers were prepared in 50mM NH~4~Cl, 50mM Tris-Acetate, 12mM MgCl~2~, 1mM DTT. To obtain a linear gradient, we used the Gradient Maker device (Hoefer SG) equipped with tubes adapted for a SW41 rotor. We used 11ml of each sucrose buffer in each gradient tube. Cytoplasmic extracts with equal amounts of RNA were loaded on the 15%--50% sucrose gradient and centrifuged at 4°C in a SW41Ti Beckman rotor for 3h30 min at 39,000 rpm Absorbance at 254 nm was recorded by BioLogic LP software (Bio-Rad) and fractions (0.5 ml each) were collected for subsequent RNA extraction.

To distinguish between active polysomes and co-sedimenting mRNPs, we treated our samples with 40 mM EDTA prior to gradient loading. Sucrose gradients were also supplemented with 30 mM EDTA and prepared without Mg^2+^.

*RNA purification.* The different fractions were pooled into 3 major fractions: cytoplasm, monosomes and polysomes. 100 μg/ml of proteinase K and 1% SDS was added to each major fraction. The fractions were then incubated for 1h30 at 37°C. 200mM NaCl and 1/4 volume of acidic phenol/chloroform/isoamyl alcohol (25:24:1) was added to the samples and the aqueous phase was transferred to a new tube. RNAs were precipitated overnight at −20°C after addition of 1 μL of glycogen and 1 volume of isopropanol. After centrifugation, RNA pellet was washed in 70% ethanol and resuspended in 120 μL of bi-distillated water. mRNAs were then re-purified using the RNeasy mini kit (QIAGEN) and eluted in 80 μL of the elution buffer of the kit. RNAs were again precipitated overnight at −20°C after addition of 40 mM Na-acetate, 1 μL of glycogen and 212 μL of ethanol 100%. After centrifugation, RNA pellet was washed in 70% ethanol and resuspended in 40 μL of bi-distillated water. The RNA concentration was measured using nanodrop. mRNAs were then reverse-transcribed and amplified by quantitative PCR.

### Quantification and statistical analysis {#sec4.4.12}

Number of replicates and statistical tests are specified in the corresponding figure legends. In all graphs, standard deviations are represented by error bars. Western blots were quantified using the Image lab software (Biorad). Raw files (.scn) were used to allow the quantification of linear and non-saturated signals. 2D gels were quantified using the Image Quant software (GE Healthcare). The mass spectrometry analysis is described in the corresponding paragraph of the [STAR Methods](#sec4){ref-type="sec"}.

### Data and software availability {#sec4.4.13}

Proteomic data as raw files, total proteins and peptides identified with relative intensities and search parameters have been loaded on the Peptide Atlas repository (<http://www.peptideatlas.org/PASS/PASS01156>). The remaining raw data have been deposited to Mendeley Data and are available at <http://dx.doi.org/10.17632/wwcrg942cf.1>.
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